IL34 and hepatocellular carcinoma: In addition, in HBV-HCC patients undergoing surgery, there was no significant change of circulating IL-34 (15.01 vs. 14.01, p > 0.05) (Fig. 1E) and MCSF (88.32 vs. 73.23; p > 0.05) (Fig. 1F) between prior to and post-surgery.